Selected News & Events

Stealth BioTherapeutics Announces Achievement of 50% Enrollment Target in Phase 3 ReNEW Study of Elamipretide in Patients with Dry Age-Related Macular Degeneration

Press Release / March 13, 2025

Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome

Press Release / January 23, 2025March 7, 2025

Stealth BioTherapeutics Announces Positive Vote from FDA Advisory Committee Meeting Supporting Potential Approval of Elamipretide for the Treatment of Barth Syndrome

Press Release / October 11, 2024March 6, 2025

Stealth BioTherapeutics to Present at UBS Virtual Ophthalmology Day

Press Release / September 27, 2024February 18, 2025

Stealth BioTherapeutics Presents New Bevemipretide (SBT-272) Data at Keystone Symposium Targeting Dry Age-Related Macular Degeneration

Press Release / September 18, 2024March 6, 2025

Events Calendar

Event Name Placeholder

Month, Year, Venue, City, State

VISIT EVENT WEBSITE

@StealthBT on Twitter

StealthBT Follow

We’re driven by a desire to help those with mitochondrial dysfunction, leading mitochondrial medicine for both rare and common diseases. https://t.co/45rgM9EXLN

StealthBT @stealthbt ·

11 Feb

People with dry AMD experience declining visual function, including blurred vision and difficulty seeing details particularly in low light. At Stealth, we are conducting a clinical study for a treatment in dry AMD.
Learn more at https://bit.ly/4gCGaoI #AMDAwarenessMonth2025

Reply on Twitter 1889315746200580600 Retweet on Twitter 1889315746200580600 Like on Twitter 1889315746200580600 1 X 1889315746200580600

StealthBT @stealthbt ·

8 Feb

Happening today the @BascomPalmerEye 2025 Angiogenesis, Exudation, and Degeneration Virtual Meeting, we are excited to share new analyses from our Phase 2 ReCLAIM-2 trial in dry age-related macular degeneration (dAMD). #dryAMD https://bit.ly/3Cwil4h

Reply on Twitter 1888247940432461909 Retweet on Twitter 1888247940432461909 Like on Twitter 1888247940432461909 X 1888247940432461909

StealthBT @stealthbt ·

7 Feb

It's #AMDAwarenessMonth2025! DYK nearly 20 million Americans aged 40+ have been diagnosed with a form of macular degeneration? Follow along with the American Macular Degeneration Foundation this month to learn about early detection, risk reduction, impact on daily living & more.

Reply on Twitter 1887967600203939937 Retweet on Twitter 1887967600203939937 Like on Twitter 1887967600203939937 X 1887967600203939937

Retweet on Twitter StealthBT Retweeted

MitoAction @mitoaction ·

3 Jan

We are just a week away from the 2025 Mito Town Meeting. We have so many wonderful people from our mito community coming to present on what they accomplished in 2024 and what they have in store for 2025. Register on our website to join us next Friday! https://buff.ly/3Dmerec

Reply on Twitter 1875270995155571018 Retweet on Twitter 1875270995155571018 1 Like on Twitter 1875270995155571018 X 1875270995155571018

Contact Us

Stealth BioTherapeutics

275 Grove Street, Suite 3-107
Newton, MA 02466
(617) 600-6888
info@stealthbt.com

Media Inquiries

media@stealthbt.com

Investor Inquiries

IR@stealthbt.com